Pub. Date : 2021
PMID : 33718200
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil. | Sildenafil Citrate | phosphodiesterase 5A | Homo sapiens |
| 2 | This is the case of sildenafil (Viagra), a phosphodiesterase-5 (PDE5) inhibitor, which was originally designed to treat systemic hypertension and angina but is currently commercialized as erectile dysfunction treatment. | Sildenafil Citrate | phosphodiesterase 5A | Homo sapiens |
| 3 | This is the case of sildenafil (Viagra), a phosphodiesterase-5 (PDE5) inhibitor, which was originally designed to treat systemic hypertension and angina but is currently commercialized as erectile dysfunction treatment. | Sildenafil Citrate | phosphodiesterase 5A | Homo sapiens |
| 4 | This is the case of sildenafil (Viagra), a phosphodiesterase-5 (PDE5) inhibitor, which was originally designed to treat systemic hypertension and angina but is currently commercialized as erectile dysfunction treatment. | Sildenafil Citrate | phosphodiesterase 5A | Homo sapiens |
| 5 | This is the case of sildenafil (Viagra), a phosphodiesterase-5 (PDE5) inhibitor, which was originally designed to treat systemic hypertension and angina but is currently commercialized as erectile dysfunction treatment. | Sildenafil Citrate | phosphodiesterase 5A | Homo sapiens |
| 6 | Sildenafil, tadalafil, and vardenafil are PDE5 inhibitors and potent vasodilators, that extend the physiological effects of nitric oxide and cyclic guanosine monophosphate (cGMP) signaling. | Sildenafil Citrate | phosphodiesterase 5A | Homo sapiens |